Healthcare Providers

Clinical Practice Guide for the Use of Therapeutics in Mild-Moderate COVID-19 (from BC)

NEW Eligibility FOR TREATMENT BASED ON APRIL 11, 2022 ANNOUNCEMENT

Is my patient with Covid at high risk (5% or greater) based on the Feb 23, 2022 Ontario Science table document? (HIGH RISK Patients)

PAXLOVID REFERRAL FORM (for Mississauga) - UPDATED April 11, 2022

Ontario Science Table - What prescribers and pharmacists need to know - PDF

University of Liverpool COVID-19 Drug Interactions

University of Michigan - Management of Paxlovid Drug-Drug interactions

ONCOLOGY drug interactions with Paxlovid - UHN - PDF

ONCOLOGY drug interactions with Paxlovid - UHN - link

Paxlovid for a Patient on a DOAC (flowsheet) - OST

ehealth centre of excellence PAXLOVID Prescription

Participating pharmacies (Paxlovid) - list from the Ministry of Health

Nirmatrelvir/Ritonavir (Paxlovid) Use in Patients With Advanced Chronic Kidney Disease and Patients on Dialysis with COVID19

Paxlovid worksheet for healthcare providers

NEJM - Article on Paxlovid

PAXLOVID - What prescribers and pharmacists need to know

Provincial referral for Remdesivir

HCCSS (Misssissauga) Remdesivir referral

Provincial sites offering Paxlovid

REFERRAL FORM FOR Covid Cold and Flu Care Clinic

OCFP resource page for Paxlovid

Locations of Covid Cold and Flu Clinic Care Clinics

SCIENCE TABLE

Paxlovid Question and Answers for Healthcare providers

Mississauga Ontario Health Team